Andere talen Faron Pharmaceuticals Oy

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:06 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
155 ^GBX	+3,33%		+6,90%	-49,18%

03/05	Kelso verhoogt belang in NCC; Transense sluit zich aan bij project	AN
30/04	Faron Pharmaceuticals Ltd. Kondigt de benoeming aan van Dr. Juho Jalkanen als directeur	CI

Kelso raises stake in NCC; Transense joins project	03/05
Update on financial status	30/04
Board Change	30/04
Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director	30/04
Faron Pharmaceuticals Oy Announces Chief Executive Officer Changes	30/04
Faron Pharmaceuticals Oy - Insider Information, Appointment of Chief Financial Officer	16/04
Faron confirms plans under new leadership	16/04
Faron Confirms Plans for the Coming Months Under New Leadership	16/04
Faron Pharmaceuticals Oy Confirms Plans for the Coming Months	16/04
Faron Pharmaceuticals reappoints former finance chief on interim basis	15/04
Faron Pharmaceuticals Appoints Interim CFO	15/04
Appointment of Chief Financial Officer	15/04
Faron Pharmaceuticals Oy Announces Chief Financial Officer Changes	15/04
Faron Pharmaceuticals promotes COO to CEO as father retires	08/04
Faron Pharmaceuticals promotes COO to CEO as founder steps back	08/04
Faron Pharmaceuticals CEO to Retire, COO Named Successor	08/04
Faron Pharmaceuticals Elects New Chair	08/04
Approval of Warrant Terms and Conditions	08/04
Decisions of the Board of Directors	08/04
Faron Pharmaceuticals Oy Announces Board Changes	08/04

Geen resultaten voor deze zoekopdracht